Here are relevant reports on : grignard-reagent-market
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030
The global healthcare dispensing systems market, valued at US$4.36 billion in 2024, stood at US$4.61 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$6.27 billion by the end of the period. The market's accelerated growth trajectory is primarily driven by increasing demand for precision dispensing in pharmaceutical manufacturing, diagnostics, and medical device production.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Europe Proteomics market, valued at USD9.80 billion in 2024, stood at USD10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of USD18.77 billion by the end of the period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Protein Stability Analysis Market by Product (Assay and Reagent, Instrument), Technique (Chromatography, Spectroscopy (DLS, Fluorescence Spectroscopy), SPR, DSF), End User (Pharmaceutical & Biotech Companies, Research Institute) - Global Forecast to 2024
The market for protein stability analysis is expected to grow from USD 1.2 billion in 2018 to USD 2.1 billion by 2024, at a CAGR of 10.0 % during the forecast period. The growth of the protein stability analysis market is primarily driven by the growing adoption of open innovation models in pharmaceutical & biotechnology companies and increasing pharmaceutical outsourcing. The major protein stability analysis vendors include PerkinElmer (US), Thermo Fisher Scientific, Inc. (US), Unchained Labs (US), NanoTemper Technologies (US), Waters Corporation (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), GE Healthcare (US), Malvern Panalytical Ltd (Spectris company) (US), Enzo Life Sciences, Inc. (US), and Horiba, Ltd (Japan).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) - Global Forecast to 2029
The global microcarriers market, valued at US$2.03B in 2023, is forecasted to grow at a 8.0% CAGR, reaching US$2.08B by 2024 and US$3.05B by 2029. Market growth is attributed to rising investments in cell & gene therapy research, growing preference for single-use technologies, and increasing R&D spending for biopharmaceutical production.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Microbiology Testing Market by Product [Instrument, Reagent & Kit, Consumable], Technology [Traditional (Manual Counting, Culture), Rapid (Nucleic Acid, Viability)], End User [Pharma, Biotech, Food, Water, Environmental Testing]-Global Forecast to 2031
The global microbiology testing market, valued at USD 7.45 billion in 2025, stood at USD 7.79 billion in 2026 and is projected to advance at a resilient CAGR of 5.3% from 2026 to 2031, culminating in a forecasted valuation of USD10.09 billion by the end of the period. The major factors driving the growth of the market include the rising need for contamination control, rising government regulations in various sectors and continuous innovation in microbiology testing.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
